BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17102561)

  • 1. How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations.
    Chatterjee S; Perignon JL; Van Marck E; Druilhe P
    J Postgrad Med; 2006; 52(4):321-4. PubMed ID: 17102561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent malaria in the natural host--irradiated sporozoites of Plasmodium berghei induce liver-stage specific immune responses in the natural host Grammomys surdaster and protect immunized Grammomys against P. berghei sporozoite challenge.
    Chatterjee S; Ngonseu E; Van Overmeir C; Correwyn A; Druilhe P; Wéry M
    Afr J Med Med Sci; 2001; 30 Suppl():25-33. PubMed ID: 14513935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
    Good MF
    Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics and Outcomes of
    Conteh S; Kolasny J; Robbins YL; Pyana P; Büscher P; Musgrove J; Butler B; Lambert L; Gorres JP; Duffy PE
    Am J Trop Med Hyg; 2020 Nov; 103(5):1893-1901. PubMed ID: 32815499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.
    Taylor-Robinson AW
    Exp Parasitol; 2010 Nov; 126(3):406-14. PubMed ID: 20138874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of the Plasmodium berghei thrombospondin-related sporozoite protein reveals a role in host cell entry by sporozoites.
    Labaied M; Camargo N; Kappe SH
    Mol Biochem Parasitol; 2007 Jun; 153(2):158-66. PubMed ID: 17418435
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Conteh S; Anderson C; Lambert L; Orr-Gonzalez S; Herrod J; Robbins YL; Carter D; Karhemere SBS; Pyana P; Büscher P; Duffy PE
    Am J Trop Med Hyg; 2017 Apr; 96(4):835-841. PubMed ID: 28115674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination using normal live sporozoites under drug treatment.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative invasion pathways for Plasmodium berghei sporozoites.
    Silvie O; Franetich JF; Boucheix C; Rubinstein E; Mazier D
    Int J Parasitol; 2007 Feb; 37(2):173-82. PubMed ID: 17112526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High road, low road? Choices and challenges on the pathway to a malaria vaccine.
    Richie T
    Parasitology; 2006; 133 Suppl():S113-44. PubMed ID: 17274843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria vaccine: a current perspective.
    Sharma S; Pathak S
    J Vector Borne Dis; 2008 Mar; 45(1):1-20. PubMed ID: 18399312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-parasite interactions for virulence and resistance in a malaria model system.
    Grech K; Watt K; Read AF
    J Evol Biol; 2006 Sep; 19(5):1620-30. PubMed ID: 16910991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-erythrocytic stage malaria vaccines: time for a change in path.
    Druilhe P; Barnwell JW
    Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learnt from mouse models for the study of malaria?
    Wykes MN; Good MF
    Eur J Immunol; 2009 Aug; 39(8):2004-7. PubMed ID: 19672886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on malaria vaccines.
    Desowitz RS; Miller LH
    Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host.
    Mota MM; Rodriguez A
    Cell Microbiol; 2004 Dec; 6(12):1113-8. PubMed ID: 15527491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.